ClinicalTrials.Veeva

Menu

Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response (OVAREX)

C

Centre Francois Baclesse

Status

Completed

Conditions

Ovarian Cancer

Treatments

Genetic: collection of blood, urine, tumor and ascite samples

Study type

Observational

Funder types

Other

Identifiers

NCT03831230
2018-A02152-53

Details and patient eligibility

About

Development of ex vivo models of ovarian cancer, fallopian tubes or peritoneum.

Enrollment

250 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient over 18 years old.
  • Patient with ovarian cancer, carcinoma of the fallopian tubes, or histologically proven peritoneum. All FIGO stages are accepted for the study.
  • Patient to be managed by surgery (laparoscopy and / or laparotomy).

Exclusion criteria

  • Pregnant woman
  • Persons deprived of liberty or guardianship (including curatorship)
  • History of any other clinically active malignancy in the last 5 years prior to inclusion

Trial contacts and locations

1

Loading...

Central trial contact

Enora DOLIVET, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems